|
US7014998B2
(en)
|
2000-09-30 |
2006-03-21 |
Yale University |
Screening immunomodulatory agents by CTLA-4 upregulation
|
|
GB0103389D0
(en)
*
|
2001-02-12 |
2001-03-28 |
Novartis Ag |
Organic compounds
|
|
US20050069538A1
(en)
|
2003-09-18 |
2005-03-31 |
Gregorio Aversa |
Therapeutic binding molecules
|
|
US7265212B2
(en)
*
|
2001-12-03 |
2007-09-04 |
Amgen Fremont Inc. |
Anti-CD45RB antibodies
|
|
US20050069549A1
(en)
|
2002-01-14 |
2005-03-31 |
William Herman |
Targeted ligands
|
|
US20030175270A1
(en)
*
|
2002-01-17 |
2003-09-18 |
Josef Penninger |
Methods of regulating cytokine receptor signaling
|
|
CA2491427A1
(en)
*
|
2002-07-01 |
2004-01-08 |
Savient Pharmaceuticals, Inc. |
Compositions and methods for therapeutic treatment
|
|
US20040146503A1
(en)
*
|
2002-08-28 |
2004-07-29 |
Tesi Raymond J. |
Methods and compositions for inducing stable immune tolerance
|
|
US20040047858A1
(en)
*
|
2002-09-11 |
2004-03-11 |
Blumberg Richard S. |
Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof
|
|
EP1658096A1
(en)
*
|
2003-08-25 |
2006-05-24 |
PanGenetics B.V. |
Method of inducing immune tolerance
|
|
DE602004026081D1
(de)
*
|
2003-09-18 |
2010-04-29 |
Novartis Ag |
Therapeutische humanisierte antikörper gegen cd45-isoformen
|
|
WO2007087453A2
(en)
*
|
2006-01-27 |
2007-08-02 |
Cellerant Therapeutics, Inc. |
Compositions and methods for treating haematological proliferative disorders
|
|
US20100034782A1
(en)
*
|
2006-05-31 |
2010-02-11 |
Nader Najafian |
Methods of Using Anti-Thymocyte Globulin and Related Agents
|
|
CN104177464B
(zh)
*
|
2006-08-18 |
2017-04-12 |
阿哥斯医疗公司 |
Cd83在联合治疗中的用途
|
|
JP2010503710A
(ja)
|
2006-09-18 |
2010-02-04 |
ラプトール ファーマシューティカル インコーポレイテッド |
受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
|
|
CN105664147A
(zh)
|
2007-02-07 |
2016-06-15 |
日本电气株式会社 |
用于癌症的治疗剂
|
|
WO2013021784A1
(ja)
*
|
2011-08-10 |
2013-02-14 |
ナパジェン ファーマ，インコーポレテッド |
免疫寛容誘導剤
|
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
|
EP2682462B1
(en)
|
2011-02-28 |
2017-11-08 |
Napajen Pharma, Inc. |
(nucleic acid)-polysaccharide complex
|
|
JP6210879B2
(ja)
*
|
2011-08-10 |
2017-10-11 |
ナパジェン ファーマ, インコーポレテッドNapaJen Pharma, Inc. |
免疫寛容誘導剤
|
|
GB201409558D0
(en)
|
2014-05-29 |
2014-07-16 |
Ucb Biopharma Sprl |
Method
|
|
GB201412658D0
(en)
|
2014-07-16 |
2014-08-27 |
Ucb Biopharma Sprl |
Molecules
|
|
GB201412659D0
(en)
|
2014-07-16 |
2014-08-27 |
Ucb Biopharma Sprl |
Molecules
|
|
US20170226209A1
(en)
*
|
2014-08-01 |
2017-08-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An anti-cd45rc antibody for use as drug
|
|
GB201601075D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies molecules
|
|
GB201601077D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibody molecule
|
|
GB201601073D0
(en)
*
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies
|
|
EP3858388B1
(en)
|
2015-09-28 |
2024-07-03 |
Regents of the University of Minnesota |
Chimeric antigen receptor (car) t cells as therapeutic interventions for gvhd
|
|
GB201521391D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521389D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Method
|
|
GB201521393D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521382D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521383D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl And Ucb Celltech |
Method
|
|
US10111966B2
(en)
|
2016-06-17 |
2018-10-30 |
Magenta Therapeutics, Inc. |
Methods for the depletion of CD117+ cells
|
|
CN109641051A
(zh)
|
2016-06-17 |
2019-04-16 |
美真达治疗公司 |
用于耗尽细胞的组合物和方法
|
|
CA3042683A1
(en)
|
2016-11-07 |
2018-05-11 |
Coimmune, Inc. |
Bispecific antibodies that modulate tlr-4 signaling and uses thereof
|
|
SG11201906319XA
(en)
|
2017-01-20 |
2019-08-27 |
Magenta Therapeutics Inc |
Compositions and methods for the depletion of cd137+ cells
|
|
EP3514541A1
(de)
|
2018-01-17 |
2019-07-24 |
Siemens Healthcare Diagnostics Products GmbH |
Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors
|
|
EP3917313A4
(en)
*
|
2019-02-01 |
2023-02-08 |
Actinium Pharmaceuticals, Inc. |
MOLECULES AND THEIR DERIVATIVES AGAINST CD45
|
|
CN111707833A
(zh)
*
|
2020-06-19 |
2020-09-25 |
徐州医科大学 |
小鼠血管内外淋巴细胞识别的方法及其应用
|
|
JP2024500189A
(ja)
|
2020-12-21 |
2024-01-04 |
アロジーン セラピューティクス，インコーポレイテッド |
プロテアーゼ活性化ｃｄ４５ゲートｃａｒ
|
|
AU2022218137A1
(en)
|
2021-02-03 |
2023-08-24 |
Mozart Therapeutics, Inc. |
Binding agents and methods of using the same
|
|
EP4310188A1
(en)
|
2021-03-17 |
2024-01-24 |
Daiichi Sankyo Company, Limited |
Gene coding for chimeric receptor for anti-acetylcholine receptor autoantibody
|
|
WO2023076876A1
(en)
|
2021-10-26 |
2023-05-04 |
Mozart Therapeutics, Inc. |
Modulation of immune responses to viral vectors
|
|
TW202346359A
(zh)
|
2022-04-15 |
2023-12-01 |
美商凱維那醫療公司 |
用於治療自體免疫疾病之方法及組合物
|
|
US20240261405A1
(en)
|
2022-06-08 |
2024-08-08 |
Kyverna Therapeutics, Inc. |
Methods and compositions for treating autoimmune disease
|
|
CN120554513B
(zh)
*
|
2025-07-28 |
2025-11-21 |
杭州华大生命科学研究院 |
一种抗cd45抗体及其应用
|